Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota

Ye Jiamei

您当前的位置：

首页 >

文章列表页 >

Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota

更新时间：2025-09-11

- Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota
- Journal of Chongqing Medical University Vol. 47, Issue 6, Pages: 676-682(2022)
- 作者机构：
  
  成都中医药大学养生康复学院,成都,610075
- 作者简介：
- 基金信息：
- DOI：
  CLC： R589
- Published：2022
- 稿件说明：
移动端阅览
Ye Jiamei. Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota[J]. Journal of chongqing medical university, 2022, 47(6): 676-682.
DOI：

Ye Jiamei. Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota[J]. Journal of chongqing medical university, 2022, 47(6): 676-682. DOI：

摘要

肥胖及其相关代谢性疾病已成为全球范围内严重影响人类健康的疾病。研究发现，菌群紊乱引起条件致病菌和有害细菌代谢产物增多，参与肥胖相关代谢性疾病的发生发展。饮食是影响肠道菌群的关键因素之一。已有大量证据表明，作为饮食干预方式之一，热量限制可明显改善肥胖、糖尿病、非酒精性脂肪肝等代谢性疾病的症状，而肠道菌群可能是其作用靶点之一。本文从肥胖、糖尿病和非酒精性脂肪肝病的肠道菌群改变、热量限制对3种代谢性疾病的治疗效果以及肠道菌群在其中的介导作用3方面进行综述。

Abstract

Obesity related metabolic diseases seriously affect human health all over the world. It's found that the disorder of gut microbiota leads to the increase of conditional pathogenic bacteria and harmful bacterial metabolites

which is involved in the occurrence and development of obesity related metabolic diseases. Diet is one of the important factors affecting gut microbiota. Caloric restriction as one of dietary intervention

a lot of evidence have proven that it can significantly improve the symptoms of metabolic diseases such as obesity

diabetes and nonalcoholic fatty liver disease. Gut microbiota may be one of its targets. Therefore

this paper reviews from such following three aspects as the changes of gut microbiota in obesity

diabetes and nonalcoholic fatty liver disease

the therapeutic effect of caloric restriction on these three metabolic diseases and the mediating role of gut microbiota in the process.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Relationship between zinc-α2-glycoprotein and insulin resistance-related diseases

The effect and mechanism of abnormal metabolism in parents on metabolism of offspring

Effect of Dachaihu decoction on dextran sodium sulfate-induced ulcerative colitis and liver injury and its association with gut microbiota modulation in mice

Research status of GLP-1 receptor agonists in the treatment of obesity

Influence of metabolic-associated fatty liver disease on the development of coronary artery disease in patients with hypertension

Related Author

Yin Jingxia

Liao Yong

Li Ling

Yang Gangyi

Lin Xiaojing

Xiang Qingqing

Lai Feng

Xiao Hong

Related Institution

Teaching and Research Section of Clinical Biochemistry，Key Laboratory of Clinical Laboratory Diagnostics Founded by Ministry of Education，Chongqing Medical University

Department of Endocrinology，Armed Police Hospital of Chongqing

Department of Endocrinology，the Second Affiliated Hospital of Chongqing Medical University

Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University

School of Public Health，Chongqing Medical University

⁰